Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT02944617Not ApplicableCompleted
Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor
DiarrheaMetastatic Renal Cell CarcinomaStage IV Renal Cell Cancer
PrincipalinvestigatorStart date: 2016-11-11
NCT01385059Phase 2Completed
Axitinib Before Surgery in Treating Patients With High-Risk Prostate Cancer
Stage III Prostate CancerStage IV Prostate Cancer
PrincipalinvestigatorStart date: 2011-10-28
NCT01157091Phase 2Completed
Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
PrincipalinvestigatorStart date: 2010-12-08

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Clear Cell Renal Cell CarcinomaMetastatic Renal Cell CarcinomaStage IV Prostate Cancer+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score17%

Brenda Sandmaier

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
12 trials

Shared therapeutic areas:

Clear Cell Renal Cell CarcinomaStage IV Renal Cell CancerRecurrent Renal Cell Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score13%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Stage IV Prostate CancerStage III Prostate Cancer
Similarity Score9%

Eric Jonasch, MD

M.D. Anderson Cancer Center

Related
14 trials

Shared therapeutic areas:

Clear Cell Renal Cell CarcinomaMetastatic Renal Cell Carcinoma
Similarity Score9%

Michael Lilly, MD

Medical University of South Carolina

Related
11 trials

Shared therapeutic areas:

Clear Cell Renal Cell CarcinomaMetastatic Renal Cell Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Sumanta K Pal

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Metastatic Renal Cell CarcinomaClear Cell Renal Cell Carcinoma

Worked with same sponsors:

City of Hope Medical CenterNational Cancer Institute (NCI)
Similarity Score9%

Vincent Chung

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Metastatic Renal Cell Carcinoma

Worked with same sponsors:

City of Hope Medical CenterNational Cancer Institute (NCI)
Similarity Score4%

Zhaohui Zhu, MD

Peking Union Medical College Hospital

Related
19 trials

Shared therapeutic areas:

Clear Cell Renal Cell Carcinoma
Similarity Score4%

Kenneth H Brown, MD

University of California, Davis

Related
8 trials

Shared therapeutic areas:

Diarrhea
Similarity Score4%

José Luis González Larriba, MD

Hospital San Carlos, Madrid

Related
2 trials

Shared therapeutic areas:

Metastatic Renal Cell Carcinoma
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT02944617Not ApplicablePrincipalInvestigator

Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor

DiarrheaMetastatic Renal Cell CarcinomaStage IV Renal Cell Cancer
Completed
NCT01385059Phase 2PrincipalInvestigator

Axitinib Before Surgery in Treating Patients With High-Risk Prostate Cancer

Stage III Prostate CancerStage IV Prostate Cancer
Completed
NCT01157091Phase 2PrincipalInvestigator

Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer

Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
Completed

All 3 trials loaded